In the absence of the alternative pathway of NF-κB activation (nfκb2−/−), a significant decrease in viability of nfκb2−/− BMDM measured by ATPmetry was observed upon fungal infection, as in control C57BL/6 macrophages (Figure 7A). This evidence concerns the gene NFKB2 and fungal infectious disease.